How does acantholysis occur in pemphigus vulgaris: a critical review

被引:52
作者
Lanza, Alessandro [1 ]
Cirillo, Nicola [1 ]
Femiano, Felice [1 ]
Gombos, Fernando [1 ]
机构
[1] Univ Naples 2, Sch Med, Reg Ctr Craniofacial Malformat, I-80100 Naples, Italy
关键词
D O I
10.1111/j.0303-6987.2006.00523.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Pemphigus vulgaris is a life-threatening autoimmune blistering disease targeting skin and mucous membranes, characterized by disruption of keratinocytes' adhesion termed acantholysis. Today multiple classes of targets are considered to play a role in the genesis of the acantholysis; of these, the classical pemphigus antigens, desmosomal cadherins (desmoglein 1 and 3) are the best characterized and considered as the most important. Additional antigens include the novel epithelial acetylcholine receptors (alpha 9 and pemphaxin). Thus, acantholysis in pemphigus seems to result from a cooperative action of antibodies to different keratinocyte self-antigens, but the mechanisms by which epithelial cleft occurs are not yet clearly understood. In fact, the binding of the autoantibodies to these targets generates a plethora of biological effects due, on one hand, to their direct interference with adhesive function and, on the other, to more complex events involving intracellular pathways that modify proteases activity or calcium metabolism, leading to loss of cell-cell adhesion.
引用
收藏
页码:401 / 412
页数:12
相关论文
共 121 条
[1]   AUTOANTIBODIES AGAINST A NOVEL EPITHELIAL CADHERIN IN PEMPHIGUS-VULGARIS, A DISEASE OF CELL-ADHESION [J].
AMAGAI, M ;
KLAUSKOVTUN, V ;
STANLEY, JR .
CELL, 1991, 67 (05) :869-877
[2]   EXTRACELLULAR DOMAIN OF PEMPHIGUS-VULGARIS ANTIGEN (DESMOGLEIN-3) MEDIATES WEAK HEMOPHILIC ADHESION [J].
AMAGAI, M ;
KARPATI, S ;
KLAUSKOVTUN, V ;
UDEY, MC ;
STANLEY, JR .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (04) :402-408
[3]   The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile [J].
Amagai, M ;
Tsunoda, K ;
Zillikens, D ;
Nagai, T ;
Nishikawa, T .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (02) :167-170
[4]   AUTOANTIBODIES AGAINST THE AMINO-TERMINAL CADHERIN-LIKE BINDING DOMAIN OF PEMPHIGUS-VULGARIS ANTIGEN ARE PATHOGENIC [J].
AMAGAI, M ;
KARPATI, S ;
PRUSSICK, R ;
KLAUSKOVTUN, V ;
STANLEY, JR .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) :919-926
[5]   ABSORPTION OF PATHOGENIC AUTOANTIBODIES BY THE EXTRACELLULAR DOMAIN OF PEMPHIGUS-VULGARIS ANTIGEN (DSG3) PRODUCED BY BACULOVIRUS [J].
AMAGAI, M ;
HASHIMOTO, T ;
SHIMIZU, N ;
NISHIKAWA, T .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) :59-67
[6]   Pemphigus vulgaris antigen (Desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients [J].
Amagai, M ;
Koch, PJ ;
Nishikawa, T ;
Stanley, JR .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (02) :351-355
[7]   Autoimmunity against desmosomal cadherins in pemphigus [J].
Amagai, M .
JOURNAL OF DERMATOLOGICAL SCIENCE, 1999, 20 (02) :92-102
[8]  
Aoyama Y, 1999, EUR J IMMUNOL, V29, P2233, DOI 10.1002/(SICI)1521-4141(199907)29:07<2233::AID-IMMU2233>3.0.CO
[9]  
2-4
[10]   Pemphigus vulgaris IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells [J].
Aoyama, Y ;
Kitajima, Y .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (01) :67-71